Home › NDC Lookup › RxCUI directory › RxCUI 1807452

2 ML diazepam 5 MG/ML Auto-Injector — RxCUI 1807452

RxNorm drug concept · Semantic clinical drug
RxCUI 1807452 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1807452
Official name2 ML diazepam 5 MG/ML Auto-Injector
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdiazepam 10 MG per 2 ML Auto-injector; diazePAM 10 MG in 2 ML Auto-injector
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diazepam Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — this medication is specifically for seizure clusters, which are episodes of repeated seizures that are different from your family member's (or your own) usual seizure pattern....
  • When exactly should I give the diazepam rectal gel — as soon as any seizure starts?
  • Yes, the prescriber may authorize a second dose, but there are rules: it can only be given 4 to 12 hours after the first dose, and only if your prescriber has said to do so in your...
  • Can I give a second dose if the seizures don't stop after the first?
📖 Read our full Diazepam Rectal guide →

🕸️ Concept Web — How 2 ML diazepam 5 MG/ML Auto-Injector Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML diazepam 5 MG/ML Auto-Injector RxCUI 1807452

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Diazepam 3322
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Diazepam Auto-Injector 1807451
    • Diazepam Injectable Product 1155859
    • Auto-Injector 1649570
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Diazepam 5 MG/ML 315799

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Diazepam 5 MG/ML SCDC · 315799
  • Diazepam Auto-Injector SCDF · 1807451
  • Diazepam Injectable Product SCDG · 1155859

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1807452 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
11704-0600-01 1 SYRINGE, GLASS in 1 POUCH (11704-600-01) / 2 mL in 1 SYRI... Diazepam Meridian Medical Technologies LLC 1990-12-05
Observed labelers: Meridian Medical Technologies LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.